|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5573924A
(en)
|
1992-09-08 |
1996-11-12 |
Immunex Corporation |
CD27 ligand
|
|
DE19747418C1
(de)
|
1997-10-27 |
1999-07-15 |
Deutsches Krebsforsch |
Inhibitor-Protein des wnt-Signalwegs
|
|
US6500633B1
(en)
|
2000-04-26 |
2002-12-31 |
Atairgin Technologies, Inc. |
Method of detecting carcinomas
|
|
US20030148321A1
(en)
|
2001-08-24 |
2003-08-07 |
Iris Pecker |
Methods and kits for diagnosing and monitoring hematopoietic cancers
|
|
AU2002351828A1
(en)
|
2001-11-05 |
2003-05-19 |
Deutsches Krebsforschungszentrum |
Novel genetic markers for leukemias
|
|
ES2394018T3
(es)
|
2001-11-27 |
2013-01-15 |
Ucb Pharma S.A. |
Procedimientos para el diagnóstico y el tratamiento de cánceres derivados de células epiteliales
|
|
US7261892B2
(en)
|
2001-11-27 |
2007-08-28 |
Celltech R&D Limited |
Methods for diagnosis and treatment of epithelial-derived cancers
|
|
US8404716B2
(en)
|
2002-10-15 |
2013-03-26 |
Celgene Corporation |
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
|
|
US8039218B2
(en)
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
|
AU2004213053C1
(en)
|
2003-02-20 |
2009-07-16 |
Seagen Inc. |
Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
US20080025989A1
(en)
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
JP5139800B2
(ja)
|
2004-06-03 |
2013-02-06 |
ノビミューン エスアー |
抗ｃｄ３抗体およびその使用方法
|
|
US8337838B2
(en)
|
2004-10-15 |
2012-12-25 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US7491390B2
(en)
|
2004-10-15 |
2009-02-17 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US7641903B2
(en)
|
2004-10-15 |
2010-01-05 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
WO2006113747A2
(en)
|
2005-04-19 |
2006-10-26 |
Prediction Sciences Llc |
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
|
|
CN101203241B
(zh)
|
2005-04-19 |
2012-02-22 |
西雅图基因公司 |
人源化抗-cd70结合物和其应用
|
|
US20080280297A1
(en)
|
2005-07-15 |
2008-11-13 |
The Trustees Of Columbia University In The City Of |
Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
|
|
CA2623236A1
(en)
|
2005-09-26 |
2007-04-05 |
Medarex, Inc. |
Human monoclonal antibodies to cd70
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
WO2007146968A2
(en)
|
2006-06-12 |
2007-12-21 |
Trubion Pharmaceuticals, Inc. |
Single-chain multivalent binding proteins with effector function
|
|
JP5097707B2
(ja)
|
2006-07-24 |
2012-12-12 |
千田建設株式会社 |
金属線材のスケール除去方法と装置
|
|
WO2008070593A2
(en)
|
2006-12-01 |
2008-06-12 |
Seattle Genetics, Inc. |
Variant target binding agents and uses thereof
|
|
KR20090088946A
(ko)
|
2006-12-14 |
2009-08-20 |
메다렉스, 인코포레이티드 |
씨디70에 결합하는 인간 항체 및 이의 용도
|
|
KR100807069B1
(ko)
|
2007-09-21 |
2008-02-25 |
고려대학교 산학협력단 |
암 치료용 의약 조성물
|
|
CN101854924A
(zh)
|
2007-11-05 |
2010-10-06 |
诺瓦提斯公司 |
测量wnt活化以及治疗wnt相关癌症的方法和组合物
|
|
GB2461546B
(en)
|
2008-07-02 |
2010-07-07 |
Argen X Bv |
Antigen binding polypeptides
|
|
WO2010014948A1
(en)
|
2008-08-01 |
2010-02-04 |
The University Of Utah Research Foundation |
Methods of treatment using wnt inhibitors
|
|
US20110190157A1
(en)
|
2008-08-15 |
2011-08-04 |
The Regents Of The University Of California |
Biomarkers for Diagnosis and Treatment of Chronic Lymphocytic Leukemia
|
|
CN103002911B
(zh)
|
2008-09-26 |
2015-08-26 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
ES2571235T3
(es)
|
2009-04-10 |
2016-05-24 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2987487B1
(en)
|
2009-08-10 |
2020-10-07 |
Samumed, LLC |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
US20120178111A1
(en)
|
2009-09-23 |
2012-07-12 |
Diamandis Eleftherios P |
Methods and compositions for the detection of lung cancers
|
|
EP2520589B1
(en)
|
2009-12-29 |
2018-11-07 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-cd27 antibody
|
|
WO2011155607A1
(ja)
|
2010-06-11 |
2011-12-15 |
協和発酵キリン株式会社 |
抗ｔｉｍ－３抗体
|
|
PT2643322T
(pt)
|
2010-11-23 |
2017-11-13 |
Abbvie Inc |
Sais e formas cristalinas de um agente indutor de apoptose
|
|
RU2597831C2
(ru)
|
2011-01-19 |
2016-09-20 |
Кантаргия Аб |
Анти-il1rap антитела и их применение при лечении людей
|
|
DK2686347T3
(en)
*
|
2011-03-16 |
2018-06-25 |
Argenx Bvba |
Antibodies against CD70
|
|
US8841418B2
(en)
|
2011-07-01 |
2014-09-23 |
Cellerant Therapeutics, Inc. |
Antibodies that specifically bind to TIM3
|
|
SG11201400859SA
(en)
|
2011-09-22 |
2014-04-28 |
Amgen Inc |
Cd27l antigen binding proteins
|
|
WO2013093508A2
(en)
|
2011-12-22 |
2013-06-27 |
Oslo University Hospital Hf |
Wnt pathway inhibitors
|
|
WO2013138586A1
(en)
|
2012-03-15 |
2013-09-19 |
Janssen Biotech, Inc. |
Human anti-cd27 antibodies, methods and uses
|
|
HK1204578A1
(en)
|
2012-03-21 |
2015-11-27 |
Erytech Pharma |
Medicament for the treatment of acute myeloid leukemia (aml)
|
|
WO2013177420A2
(en)
|
2012-05-23 |
2013-11-28 |
St. Jude Children's Research Hospital |
Methods and compositions for the treatment of bcr-abl positive lymphoblastic leukemias
|
|
CN106188045B
(zh)
|
2012-06-15 |
2018-01-16 |
广州源生医药科技有限公司 |
作为wnt信号传导抑制剂的化合物、组合物及其应用
|
|
WO2014045101A1
(en)
|
2012-09-21 |
2014-03-27 |
Cellzome Gmbh |
Tetrazolo quinoxaline derivatives as tankyrase inhibitors
|
|
WO2014100772A1
(en)
|
2012-12-21 |
2014-06-26 |
Cellerant Therapeutics, Inc. |
Antibodies that bind membrane-bound il1rap
|
|
RS56169B1
(sr)
|
2013-02-14 |
2017-11-30 |
Bristol Myers Squibb Co |
Jedinjenja tubulisina, metode pripreme i primena
|
|
EP3099717B1
(en)
|
2014-01-31 |
2019-03-27 |
Novartis AG |
Antibody molecules to tim-3 and uses thereof
|
|
AU2015229448B2
(en)
|
2014-03-11 |
2020-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anti SIRP-alpha antibodies and Bi-specific Macrophage Enhancing antibodies
|
|
US20160200815A1
(en)
|
2015-01-05 |
2016-07-14 |
Jounce Therapeutics, Inc. |
Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究（慕尼黑）公司 |
Ｃｄ７０及ｃｄ３抗體構築體
|
|
WO2017044752A1
(en)
|
2015-09-10 |
2017-03-16 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Anti-fibrotic effect of cd70
|
|
EP3370768B9
(en)
|
2015-11-03 |
2022-03-16 |
Janssen Biotech, Inc. |
Antibodies specifically binding pd-1 and their uses
|
|
AU2016349279A1
(en)
*
|
2015-11-03 |
2018-05-10 |
Board Of Regents, The University Of Texas System |
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer
|
|
EP3426655A1
(en)
|
2016-03-10 |
2019-01-16 |
Assia Chemical Industries Ltd. |
Solid state forms of venetoclax and processes for preparation of venetoclax
|
|
WO2017160954A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
CN109563096A
(zh)
|
2016-06-09 |
2019-04-02 |
雷迪博士实验室有限公司 |
固体形式的维奈托克和用于制备维奈托克的方法
|
|
EP3481397A1
(en)
|
2016-07-06 |
2019-05-15 |
Concert Pharmaceuticals Inc. |
Deuterated venetoclax
|
|
CN107648185A
(zh)
|
2016-07-25 |
2018-02-02 |
常州爱诺新睿医药技术有限公司 |
一种无定型Venetoclax与药用辅料的固体分散体及其制备方法
|
|
WO2018029711A2
(en)
|
2016-08-12 |
2018-02-15 |
Mylan Laboratories Limited |
Process for the preparation of venetoclax
|
|
US10800777B2
(en)
|
2016-10-14 |
2020-10-13 |
Mylan Laboratories Limited |
Polymorphic forms of VENCLEXTA
|
|
EP3333167A1
(en)
|
2016-12-09 |
2018-06-13 |
LEK Pharmaceuticals d.d. |
Solid forms of venetoclax
|
|
CZ201769A3
(cs)
|
2017-02-06 |
2018-08-15 |
Zentiva, K.S. |
Pevné formy venetoclaxu
|
|
WO2018157803A1
(zh)
|
2017-02-28 |
2018-09-07 |
苏州科睿思制药有限公司 |
维奈妥拉的晶型及其制备方法
|
|
WO2018167652A1
(en)
|
2017-03-13 |
2018-09-20 |
Laurus Labs Limited |
Process for preparation of amorphous form of venetoclax
|
|
CN107089981A
(zh)
|
2017-04-24 |
2017-08-25 |
杭州科耀医药科技有限公司 |
一种BCL‑2抑制剂Venetoclax的合成方法
|
|
GB2567613A
(en)
*
|
2017-06-16 |
2019-04-24 |
Argenx Bvba |
Treatment for acute myeloid leukaemia
|
|
GB201800649D0
(en)
*
|
2018-01-16 |
2018-02-28 |
Argenx Bvba |
CD70 Combination Therapy
|
|
TWI848030B
(zh)
|
2018-12-18 |
2024-07-11 |
比利時商阿根思公司 |
Ｃｄ７０組合治療
|